Role of liver peroxisomes in bile acid formation: Inborn error of C²⁷-steroid side chain cleavage in peroxisome deficiency (Zellweger syndrome)

References

• Palmer R H. Bile salts and the liver. Progress in Liver Diseases, H Popper, F Schaffner. Grune & Stratton Inc, New York 1982; 221–42
   Google Scholar
• Small D M. The physical chemistry of cholanic acids. The Bile Acids, P P Nair, D Kritchevsky. Plenum Press, New York 1972; vol I: 249–356
   Google Scholar
• Hoffman A F, Makhjian H S. Bile acids and the intestinal absorption of fat and electrolytes in health and disease. The Bile Acids, P P Nair, D Kritchevsky. Plenum Press, New York 1973; vol II: 103–52
   Google Scholar
• Bloch K, Berg B N, Rittenberg D. The biological conversion of cholesterol to cholic acid. J Biol Chem 1943; 149: 511–17
   Google Scholar
• Björkhem I. Mechanism of bile acid biosynthesis in mammalian liver. Comprehensive Biochemistry. Elsevier Scientific Publishing Co, Amsterdam 1985; Vol 12: 231–78
   Google Scholar
• Bjorkhem I, Danielsson H. 7α-Hydroxylation of exogenous and endogenous cholesterol in rat-liver microsomes. Eur J Biochem 1975; 53: 63–70
   Google Scholar
• Mitropoulos K A, Venkatesan S, Balasub-Ramaniam S, Peters T J. The submicro-somal localization of 3-hydroxy-3-methyl-glutaryl-coenzyme-A reductase, cholesterol 7a-hydroxylase and cholesterol in rat liver. Eur J Biochem 1978; 82: 419–29
   PubMedGoogle Scholar
• Danielsson H, Einarsson K. On the conversion of cholesterol to 7α,12α-dihydroxycholest-4-en-3-one. Bile acids and steroids 168. J Biol Chem 1966; 241: 1449–54
   PubMed Web of Science ®Google Scholar
• Berséus O. Conversion of cholesterol to bile acids in rat: purification and properties of a delta 4–3-ketosteroid 5β-reductase and a 3a-hyroxysteroid dehydrogenase. Bile acids and steroids 187. Eur J Biochem 1967; 2: 493–502
   PubMedGoogle Scholar
• Björkhem I, Gustafsson J. Mitochondrial omega-hydroxylation of cholesterol side chain. J Biol Chem 1974; 249: 2528–35
   PubMed Web of Science ®Google Scholar
• Oftebro H, Saarem K, Björkhem I, Pedersen J I. Side chain hydroxylation of C27-steroids and vitamin D3 by a cytochrome P-450 enzyme system isolated from human liver mitochondria. J Lipid Res 1981; 22: 1254–64
   PubMed Web of Science ®Google Scholar
• Prydz K, Kase B F, Bjorkhem I, Pedersen J I. Subcellular localization of 3x,7a-dihydroxy- and 3α,7α,12α-trihydroxy-5β-cholestanoyl-coenzyme A ligase(s) in rat liver. J Lipid Res 1988; 29: 997–1005
   PubMed Web of Science ®Google Scholar
• Masui T, Staple E. The formation of bile acids from cholesterol. The conversion of 5β-cholestane-3α, 7α, 12α-triol-26-oic acid to cholic acid via 5β-cholestane-3a, 7α, 12α, 24-tetraol-26-oic acid by rat liver. J Biol Chem 1966; 241: 3889–93
   PubMed Web of Science ®Google Scholar
• Gustafsson J. Biosynthesis of cholic acid in rat liver: formation of cholic acid from 3α, 7α, 12α-trihydroxy- and 3α,7α,12α,24-tetrahydroxy-5β-cholestanoic acids. Lipids 1980; 15: 113–21
   PubMed Web of Science ®Google Scholar
• Pedersen J I, Gustafsson J. Conversion of 3α,7α,12α -trihydroxy-5β-cholestanoic acid into cholic acid by rat liver peroxisomes. FEBS Lett 1980; 121: 345–48
   PubMed Web of Science ®Google Scholar
• Killenberg P G. Measurement and subcellular distribution of cholyl-CoA synthetase and bile acid-CoA: amino acid N-acyl-transferase activities in rat liver. J Lipid Res 1978; 19: 24–31
   PubMed Web of Science ®Google Scholar
• Kase B F, Prydz K, Björkhem I, Pedersen J I. Conjugation of cholic acid with taurine and glycine by rat liver peroxisomes. Bio-chem Biophys Res Comm 1986; 138: 167–73
   PubMed Web of Science ®Google Scholar
• Shefer S, Cheng F W, Dayal B, Hauser S, Tint G S, Salen G, Mosbach E H. A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat. J Clin Invest 1975; 57: 897–903
   Web of Science ®Google Scholar
• Swell L, Gustafsson J, Schwartz C C, Halloran L G, Danielsson H, Vlahcevic Z R. An in vivo evaluation of the quantitative significance of several potential pathways to cholic acid and chenodeoxy-cholic acid from cholesterol in man. J Lipid Res 1980; 21: 455–66
   PubMed Web of Science ®Google Scholar
• DeDuve C. Functions of microbodies (peroxisomes). J Cell Biol 1965; 27: 25A–26A
   PubMed Web of Science ®Google Scholar
• Hashimoto T. Individual peroxisomal β-oxidation enzymes. Ann NY Acad Sci 1982; 386: 5–12
   PubMed Web of Science ®Google Scholar
• Hajra A K, Bishop J E. Glycerolipid biosynthesis in peroxisomes via the acyl di-hydroxyacetone phosphate pathway. Ann NY Acad Sa 1982; 386: 170–81
   PubMed Web of Science ®Google Scholar
• Demopoulos C A, Pinckard R N, Hanahan D J. Platelet-activating factor: evidence for l-0-alkyl-2-acetyl-sn-glyceryl-3-phos-phorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979; 254: 9355–8
   PubMed Web of Science ®Google Scholar
• Trijbels J, Monnens L, Bakkeren J, van Raay-Selten A. Biochemical studies in the cerebrohepato-renal syndrome of Zellweger: a disturbance in the metabolism of pipecolic acid. J Inher Metab Dis 1979; 2: 39–42
   Google Scholar
• Vamecq J, van Hoof F. Implication of a peroxisomal enzyme in the catabolism of glutaryl-CoA. Biochem J 1984; 221: 203–11
   PubMed Web of Science ®Google Scholar
• Skjeldal O, Stokke O. Defective phytanic acid oxidase in neonatal adrenoleuko-dystrophy. J Neurology 1985; 232(Suppl. 289)
   Google Scholar
• Bowen P, Lee C, Zellweger H, Lindenberg R. A familial syndrome of multiple congenital defects. Bull Johns Hopkins Hosp 1964; 114: 402–14
   PubMedGoogle Scholar
• Opitz J, Zu Rhein G, Vitale L, Shahidi N, Howe J, Chou S, Shanklin D, Sybers H, Dood A, Gerritsen T. The Zellweger syndrome (cerebro-hepato-renal syndrome). 1969; vol V: 144–58, Birth Defects: the original article series No. 2
   Google Scholar
• Goldfischer S, Moore C, Johnson A, Spiro A, Valsamis M, Wisniewski H, Ritch R, Norton W, Rapin I, Gartner L. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 1973; 182: 62–4
   PubMed Web of Science ®Google Scholar
• Kelley R I. Review: The cerebrohepato-renal syndrome of Zellweger, morphological and metabolic aspects. Am J Med Gen 1983; 16: 503–17
   PubMed Web of Science ®Google Scholar
• Zellweger H. The cerebro-hepato-renal (Zellweger) syndrome and other peroxisomal disorders. Developmental Medicine and Child Neurology 1987; 29: 821–9
   PubMed Web of Science ®Google Scholar
• Eyssen H, Parmentier G, Compernolle F, Boon J, Eggermont E. Trihydroxy-coprostanic acid in the duodenal fluid of two children with intrahepatic bile duct anomalies. Biochim Biophys Acta 1972; 273: 212–21
   PubMed Web of Science ®Google Scholar
• Hanson R, Szczepanik-van Leeuwen P, Williams G, Grabowski G, Sharp H. Defects of bile acid synthesis in Zellweger's syndrome. Science 1979; 203: 1107–8
   PubMed Web of Science ®Google Scholar
• Monnens L, Bakkeren J, Parmentier G, van Haelst U, Trijbels J, Eyssen H. Disturbances in bile acid metabolism of infants with the Zellweger (cerebrohepato-renal) syndrome. Eur J Pedatr 1980; 133: 31–5
   PubMed Web of Science ®Google Scholar
• Parmentier G, Janssen G A, Eggermont E A, Eyssen E J. C27 Bile acids in infants with coprostanic acidemia and occurrence of a 3α, 7α, 12α -trihydroxy-5β-C29 dicarboxylic bile acid as a major component in their serum. Eur J Biochem 1979; 102: 173–83
   PubMedGoogle Scholar
• Kase B F, Björkhem I, Pedersen J I. Formation of cholic acid from 3α, 7α 12α-trihydroxy-5β-cholestanoic acid by rat liver peroxisomes. J Lipid Res 1983; 24: 1560–7
   PubMed Web of Science ®Google Scholar
• Björkhem I, Kase B F, Pedersen J I. Mechanism of peroxisomal 24-hydroxy-lation of 3α, 7α, 12α -trihydroxy-5β-cholestanoic acid in rat liver. Biochim Biophys Acta 1984; 796: 142–5
   PubMedGoogle Scholar
• Kase B F, Prydz K, Björkhem I, Pedersen J I. In vitro formation of bile acids in human liver peroxisomes. Biochem Biophys Acta 1986; 877: 37–42
   PubMedGoogle Scholar
• Kase B F, Pedersen J, Strandvik I. B, Björkhem I. In vivo and in vitro studies on formation of bile acids in patients with the Zellweger syndrome. Evidence that peroxisomes are of importance in the normal biosynthesis of both cholic and chenodeoxycholic acid. J Clin Invest 1985; 76: 2393–2402
   PubMed Web of Science ®Google Scholar
• Kase B F, Björkhem I, Hågå P, Pedersen J I. Defective peroxisomal cleavage of the C27-steroid side chain in the cerebro-hepato-renal syndrome of Zellweger. J Clin Invest 1985; 75: 427–35
   PubMed Web of Science ®Google Scholar
• Ek J, Kase B F, Reith A, Björkhem I, Pedersen J I. Peroxisomal dysfunction in a boy with neurologic symptoms and amaurosis (Leber disease): Clinical and biochemical findings similar to those observed in Zellweger syndrome. J Pediatrics 1986; 108: 19–24
   PubMed Web of Science ®Google Scholar
• Prydz K, Kase B F, Björkhem I, Pedersen J I. Formation of chenodeoxycholic acid from 3a,7a-dihydroxy-5fJ-cholestanoic acid by rat liver peroxisomes. J Lipid Res 1986; 27: 622–8
   PubMed Web of Science ®Google Scholar
• Lazarow P B. Rat liver peroxisomes catalyze the β-oxidation of fatty acids. J Biol Chem 1978; 253: 1522–8
   PubMed Web of Science ®Google Scholar
• Tager J M, Van Der Beek W A, Wanders R JA, Hashimoto T, Heymans H SA, Van Den Bosch H, Schutgens R BH, Schram A W. Peroxisomal β-oxidation enzyme proteins in the Zellweger syndrome. Biochem Biophys Res Commun 1985; 126: 1269–75
   PubMed Web of Science ®Google Scholar
• Trijbels J MF, Berden J A, Monnens L AH, Willems J L, Jansen A JM, Schutgens R BH, Van Den Broek-Van Essen M. Biochemical studies in the liver and muscle of patients with Zellweger syndrome. Pediatr Res 1983; 17: 514–7
   PubMed Web of Science ®Google Scholar
• Björkhem I, Kase B F, Pedersen J I. Role of peroxisomes in the biosynthesis of bile acids. Scand J Clin Lab Invest 1985; 177(45 Suppl)23–31
   Google Scholar
• Hanson R F, Klein P D, Williams G C. Bile acid formation in man: metabolism of 7α-hydroxy-4-cholesten-3-one in bile fistula patients. J Lipid Res 1973; 14: 50–3
   PubMed Web of Science ®Google Scholar
• Swell L, Gustafsson J, Danielsson H, Schwartz C C, Vlahcevic Z R. Biosynthesis of bile acids in man. An in vivo evaluation of the conversion of R and S 3α, 7α, 12α-trihydroxy-5β-cholestanoic and 3α,7α,12α, 24-tetrahydroxy-5β-cholestanoic acids to cholic acid. J Biol Chem 1981; 256: 912–6
   PubMed Web of Science ®Google Scholar
• Björkhem I, Liljeqvist L, Nilsell K, Einarsson K. Oxidoreduction of different hydroxyl groups in bile acids during their enterohepatic circulation in man. J Lipid Res 1986; 27: 177–82
   PubMed Web of Science ®Google Scholar
• Watkins J B, Ingall D, Szczepanik P, Klein P D, Lester R. Bile salt metabolism in the newborn. Measurement of pool size and synthesis by stable isotope technic. N Eng J Med 1973; 288: 431–4
   PubMed Web of Science ®Google Scholar
• Heubi J E, Balistreri W F, Suchy F J. Bile salt metabolism in the first year of life. J Lab Clin Med 1982; 100: 127–36
   PubMed Web of Science ®Google Scholar
• Lee M J, Whitehouse M W. Inhibition of electron transport and coupled phosphorylation in liver mitochondria by cholanic (bile) acids and their conjugates. Biochem Biophys Acta 1965; 100: 317–28
   PubMedGoogle Scholar